03:20 AM EDT, 08/28/2026 (MT Newswires) -- Imaging platforms and therapeutics group Imaging Biometrics' (IBAI.L) US subsidiary signed a renewable annual subscription agreement with a major academic medical center in the Midwest for its IB Clinic automated brain tumor imaging software. The center will use the software to assess brain tumor patients and treatment response. IB Clinic measures blood flow and generates maps to help distinguish tumors from treatment effects, according to a Friday release. The adoption also enables the center to halve the amount of contrast agent injected into patients.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.